Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis
利福喷丁/异烟肼治疗潜伏性结核病1个月期间血浆多替拉韦暴露的药物遗传学
期刊:Pharmacogenetics and Genomics
影响因子:1.7
doi:10.1097/FPC.0000000000000562
Covington, Nia; Luetkemeyer, Anne F; Imperial, Marjorie Z; Dawson, Rodney; Cramer, Yoninah; Rosenkranz, Sue; Swindells, Susan; Gelmanova, Irina; Avihingsanon, Anchalee; Arduino, Roberto C; Samaneka, Wadzanai; Dooley, Kelly E; Savic, Rada; Podany, Anthony T; Haas, David W